Acute and subchronic effects of bilastine (20 and 40 mg) and hydroxyzine (50 mg) on actual driving performance in healthy volunteers.

Author: ConenSilke, RamaekersJohannes G, TheunissenEef L, ValienteRomán, Van OersAnita C M

Paper Details 
Original Abstract of the Article :
Bilastine is a new second-generation H1 antagonist. Although bilastine has been demonstrated to produce little or no performance impairment in laboratory tests, it cannot be excluded that it produces impairments in real-life performance such as driving. This study aims to assess the effects of two d...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/0269881110382467

データ提供:米国国立医学図書館(NLM)

Driving Performance: Bilastine vs. Hydroxyzine

This research investigates the effects of bilastine, a new second-generation H1 antagonist, on actual driving performance. The study compared the effects of bilastine at two doses (20 mg and 40 mg) to those of hydroxyzine (50 mg) in healthy volunteers. The study employed a placebo-controlled, randomized, double-blind, four-way crossover design with participants performing actual highway driving tests after single and repeated administration of the medications. The findings indicate that hydroxyzine significantly impaired driving performance, while bilastine had no adverse effects on driving.

Bilastine: No Adverse Effects on Driving Performance

The study found that hydroxyzine significantly increased weaving, a measure of driving impairment, after both single and repeated doses. In contrast, bilastine, even at the higher dose, did not affect driving performance. These findings suggest that bilastine might be a safer option for patients who need to drive, as it appears to have no significant impact on driving abilities.

Navigating Medication and Driving

This research provides valuable information for patients who need to drive and are considering medication. It highlights the importance of consulting with a healthcare professional to discuss potential side effects and their implications for driving safety. Just as a camel carefully navigates treacherous dunes in the desert, drivers should be aware of the potential risks of medications and make informed decisions about their safety on the road.

Dr.Camel's Conclusion

This research underscores the importance of understanding the potential effects of medications on driving performance. It emphasizes the need for careful consideration and consultation with healthcare professionals to ensure safe driving practices. Like a skilled camel navigating a winding desert path, we must be mindful of potential risks and adapt our approach to ensure a smooth and safe journey.

Date :
  1. Date Completed 2012-06-27
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

20855350

DOI: Digital Object Identifier

10.1177/0269881110382467

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.